DIETARY SOY ISOFLAVONES AND PROSTATE CANCER PROGRESSION
膳食大豆异黄酮与前列腺癌进展
基本信息
- 批准号:2712797
- 负责人:
- 金额:$ 3.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-15 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The objective of this proposal is to investigate the preventive role of
soy isoflavones in prostate cancer (PCA) progression and angiogenesis. The
specific aims are: l) to study the effects of soy isoflavones on
inhibiting expression of membrane-type metalloproteinase (MT-MMP) by PCA
cells, fibroblasts, or endothelial cells (ECs) in vitro, and 2) to
determine if diets containing soy protein isolate (SPI) or purified
isoflavones inhibit prostate tumor progression, angiogenesis, and MT-MMP
expression in vivo. Human PCA cells (PC-3, DU 145, and LNCAP),
fibroblasts, and ECs will be treated with isoflavones. MMPs-containing
conditioned media and MT-MMP-containing plasma membranes will be prepared.
RNase protection assays, Western blotting, and zymography will be applied
to determine mRNA, protein, and activity of MT-MMP to test the hypothesis
that isoflavones inhibit PCA progression, and prostate tumor angiogenesis
by inhibiting MT-MMP expression by PCA and fibroblasts, and ECs,
respectively. In animal study, human PCA cell-inoculated nude mice will be
fed control, SPI-based, or isoflavone-supplemented diets. Tumor sizes will
be measured, and tumors removed for determinations of MT-MMP mRNA, protein
and activity to evaluate the effects of isoflavones on in vivo inhibition
of PCA progression. Anti-angiogenic effect of isoflavones will be
evaluated by immunohistochemical analysis of microvessels.
这项建议的目的是调查……的预防作用
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
生物活性大豆成分抑制小鼠体内雄激素敏感的人类前列腺肿瘤的原位生长和转移。
- DOI:10.1002/pros.10141
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Zhou,Jin-Rong;Yu,Lunyin;Zhong,Ying;Nassr,RenaL;Franke,AdrianA;Gaston,SandraM;Blackburn,GeorgeL
- 通讯作者:Blackburn,GeorgeL
Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
- DOI:10.1016/s0022-5347(05)68638-7
- 发表时间:1998-11
- 期刊:
- 影响因子:11.2
- 作者:Jin-Rong Zhou;P. Mukherjee;Eric Gugger;Toshihide Tanaka;G. Blackburn;S. Clinton
- 通讯作者:Jin-Rong Zhou;P. Mukherjee;Eric Gugger;Toshihide Tanaka;G. Blackburn;S. Clinton
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
大豆植物化学物质和茶生物活性成分可协同抑制小鼠体内雄激素敏感的人类前列腺肿瘤。
- DOI:10.1093/jn/133.2.516
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Zhou,Jin-Rong;Yu,Lunyin;Zhong,Ying;Blackburn,GeorgeL
- 通讯作者:Blackburn,GeorgeL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIN-RONG ZHOU其他文献
JIN-RONG ZHOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIN-RONG ZHOU', 18)}}的其他基金
Tanshinones for prevention of bladder cancer progression
丹参酮预防膀胱癌进展
- 批准号:
8296497 - 财政年份:2011
- 资助金额:
$ 3.05万 - 项目类别:
Targeting prostate cancer stem cells to delay prostate cancer progression
靶向前列腺癌干细胞以延缓前列腺癌进展
- 批准号:
8190865 - 财政年份:2011
- 资助金额:
$ 3.05万 - 项目类别:
Tanshinones for prevention of bladder cancer progression
丹参酮预防膀胱癌进展
- 批准号:
8203196 - 财政年份:2011
- 资助金额:
$ 3.05万 - 项目类别:
Targeting prostate cancer stem cells to delay prostate cancer progression
靶向前列腺癌干细胞以延缓前列腺癌进展
- 批准号:
8286889 - 财政年份:2011
- 资助金额:
$ 3.05万 - 项目类别:
Metabolic Syndrome as Pancreatic Cancer Etiology
代谢综合征作为胰腺癌的病因
- 批准号:
7469288 - 财政年份:2008
- 资助金额:
$ 3.05万 - 项目类别:
Metabolic Syndrome as Pancreatic Cancer Etiology
代谢综合征作为胰腺癌的病因
- 批准号:
7609157 - 财政年份:2008
- 资助金额:
$ 3.05万 - 项目类别:
Parental metabolic status and offspring cancer risks
父母代谢状况和后代癌症风险
- 批准号:
7491579 - 财政年份:2007
- 资助金额:
$ 3.05万 - 项目类别:
Synergy between phytochemicals for prostate cancer prevention
植物化学物质之间的协同作用预防前列腺癌
- 批准号:
7322669 - 财政年份:2007
- 资助金额:
$ 3.05万 - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 3.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 3.05万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 3.05万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 3.05万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 3.05万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 3.05万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 3.05万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 3.05万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 3.05万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 3.05万 - 项目类别:














{{item.name}}会员




